GSK and Enigma Diagnostics announce commercial partnership to develop point-of-care influenza diagnostics
GSK & Enigma have signed agreements to develop and supply influenza tests to identify virus strains using its real-time PCR technology.
Read the full article17y agoen
You might also wanna read
OpenAI No. 2 Executive Fidji Simo Steps Down from Full-Time Role to Focus on Health Recovery
Variety·5h ago
Why ambulance rides in the US are so expensive: The broken economics of emergency medical transport
davidoks.blog·7h agoModerna's mResvia gets shot in the arm from EU contract
pharmaphorum·7h ago
Australia news live: Hanson defends UK ‘fact-finding’ trip; Qantas tops airline punctuality table
The Guardian·7h ago
STAT+: FDA finalists under review
STAT·14h ago
STAT+: Prime wins Beam arbitration, clearing path to clinic
STAT·15h ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.